ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China · Delayed Price · Currency is CNY 35.59
-1.01 (-2.76%)
Sep 4, 2026, 3:04 PM CST
SHE:300723 Revenue
ApicHope Pharmaceutical Group had revenue of 106.25M CNY in the quarter ending June 30, 2026, a decrease of -48.63%. This brings the company's revenue in the last twelve months to 840.19M, down -25.08% year-over-year. In the year 2025, ApicHope Pharmaceutical Group had annual revenue of 932.27M, down -35.72%.
Revenue (ttm)
840.19M
Revenue Growth
-25.08%
P/S Ratio
19.00
Revenue / Employee
649.30K
Employees
1,294
Market Cap
15.96B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 932.27M | -517.96M | -35.72% |
| Dec 31, 2024 | 1.45B | -1.05B | -42.07% |
| Dec 31, 2023 | 2.50B | 223.25M | 9.79% |
| Jan 1, 2023 | 2.28B | 80.98M | 3.68% |
| Dec 31, 2021 | 2.20B | 523.80M | 31.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.